Your browser doesn't support javascript.
loading
Changing trends in a decade of vascular radiology-the impact of technical developments of non-invasive techniques on vascular imaging.
Cowell, Gordon W; Reid, Allan W; Roditi, Giles H.
Afiliación
  • Cowell GW; Department of Radiology, Glasgow Royal Infirmary, Alexandra Parade, Glasgow, G4 0SF,, Scotland, United Kingdom, gordoncowell@nhs.net.
Insights Imaging ; 3(5): 495-504, 2012 Oct.
Article en En | MEDLINE | ID: mdl-22865510
ABSTRACT

OBJECTIVES:

This review aims to establish the impact on conventional angiography and endovascular intervention of contrast-enhanced magnetic resonance angiography (CE-MRA) and contrast-enhanced computed tomography angiography (CE-CTA) on a background of evolving technology, changing clinical requirements and resulting clinical repercussions.

METHODS:

The angiographic and interventional caseload was prospectively recorded between 1997 and 2010, along with the CE-MRA and CE-CTA caseload. Waiting times and the marginal cost analyses for 2001 and 2009 were also prospectively established.

RESULTS:

Conventional diagnostic angiographies declined from a peak of 847 to 121 per year while endovascular interventions continue in similar numbers. CE-MRA increased from effectively none initially to 620 per year while CE-CTA has currently risen to 396 per year. Total diagnostic study numbers have increased but at reduced cost. Various influences are clear, including on-site modality availability, capability and accuracy along with impact of new therapies, research studies and adverse events.

CONCLUSIONS:

Vascular imaging has undergone a metamorphosis in little over a decade because of CE-MRA and CE-CTA. With waiting times significantly reduced since the start of the study and the cost-effectiveness of both CE-MRA and CE-CTA as primary diagnostic investigations established, further development of these services is inevitable. MAIN MESSAGES • The availability of CE-MRA and CE-CTA has reduced the need for conventional angiography. • Both waiting times and the marginal cost analyses for CE-MRA and CE-CTA have reduced. • The impact of new therapies, research studies (e.g. ASTRAL) and adverse events is illustrated.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Insights Imaging Año: 2012 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Insights Imaging Año: 2012 Tipo del documento: Article